:)

http://finance.yahoo.com/news/Accuray-An...

SUNNYVALE, Calif., Sept. 15 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY - News), a global leader in the field of radiosurgery, announced today that Accuray's Board of Directors has appointed Louis J. Lavigne, Jr. and Dennis L. Winger as members of the company's Board of Directors.

Lavigne is currently a management consultant specializing in the areas of corporate finance, accounting and strategy. Lavigne was Chief Financial Officer of Genentech, Inc., from 1988 and also served as the company's Executive Vice President from 1997 until his retirement in 2005. Lavigne sits on the Board of Trustees for Caltech (The California Institute of Technology) and also serves on the boards of directors of Allergan, Inc. and BMC Software, Inc., where he also chairs the Audit Committee.

Winger most recently served as Senior Vice President and Chief Financial Officer with Applied Biosystems, Inc. from 1997 to 2008. Prior to that, from 1989 to 1997, he was the Senior Vice President, Finance and Administration and Chief Financial Officer of Chiron Corporation. Winger also serves on the boards of directors of Cell Genesys, Inc., Cephalon, Inc. and Vertex Pharmaceuticals.

"We are pleased to have two of the industry's most skilled veterans join Accuray's Board of Directors, and we look forward to benefiting from their insight and experience," said Wayne Wu, Accuray Chairman.

It is expected that Lavigne will serve on the Audit Committee of the Board of Directors and Winger will serve on the Compensation Committee of the Board of the Directors.

About the CyberKnife® Robotic Radiosurgery System

The CyberKnife Robotic Radiosurgery System is the world's only robotic radiosurgery system designed to treat tumors anywhere in the body non-invasively. Using continual image guidance technology and computer controlled robotic mobility, the CyberKnife System automatically tracks, detects and corrects for tumor and patient movement in real-time throughout the treatment. This enables the CyberKnife System to deliver high-dose radiation with pinpoint precision, which minimizes damage to surrounding healthy tissue and eliminates the need for invasive head or body stabilization frames.